0001555280-20-000318.txt : 20201117
0001555280-20-000318.hdr.sgml : 20201117
20201117163031
ACCESSION NUMBER: 0001555280-20-000318
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201113
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alaix Juan Ramon
CENTRAL INDEX KEY: 0001567824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 201321518
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_160564861834659.xml
FORM 4
X0306
4
2020-11-13
0
0001555280
Zoetis Inc.
ZTS
0001567824
Alaix Juan Ramon
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
1
0
0
0
Common Stock
2020-11-13
4
S
0
69319
165.29
D
26694
D
Common Stock
2020-11-13
4
S
0
22428
165.99
D
4266
D
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.59 to $165.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.59 to $166.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Katherine H. Walden, as Attorney-in-Fact
2020-11-17